ACF Investors
ACF Investors, established in 2011 and based in Sheffield, United Kingdom, operates as a venture capital entity that collaborates with experienced angel investors to support early-stage businesses. The firm focuses on co-investing alongside syndicates of angel investors, leveraging their sector-specific expertise to identify and fund high-potential companies. ACF Investors has built a strong portfolio, having invested over £40 million in partnership with more than £200 million from angel investors and other sources, resulting in a diverse collection of over 80 companies. The organization is dedicated to fostering the growth of small and medium-sized enterprises throughout the UK, often providing support through multiple funding rounds as these companies scale.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Industrial Gases
Hexigone Inhibitors
Venture Round in 2024
Hexigone aims to replace toxic chemicals used in the anti-corrosion market with our disruptive, novel, micro/nano reservoir technologies, creating 'smart' coatings. Our additives will enable the coatings to protect for longer in an intelligent manner, increasing the lifetime cycle of the end product, reducing the drain on primary resources.
IMSPEX Diagnostics
Venture Round in 2014
IMSPEX Diagnostics Ltd. develops analytical solutions leveraging ion mobility spectrometry technology for various applications, including clinical diagnostics, environmental analysis, and food safety. Founded in 2011 as a spinoff from the University of Glamorgan, the company produces several instruments, such as FlavourSpec, which analyzes the headspace of liquid samples to assess food freshness and optimize production processes in the food and beverage sectors. Another key product, BreathSpec, examines volatile organic compounds in human breath, aiding in disease detection and monitoring hazardous exposure in workplaces. Additionally, IMSPEX offers GC-IMS, which identifies siloxanes in biogas, assesses air safety in industrial environments, and detects natural gas odors. The company serves a diverse clientele, including blue-chip companies, research hospitals, and universities both in the United Kingdom and internationally. Through its acquisition of GAS GmbH in 2013, IMSPEX enhanced its technological capabilities and market presence, establishing itself as a leader in its field.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.